Abstract: |
The DNA-dependent protein kinase (DNA-PK) consists of a heterodimer DNA- binding complex, Ku70 and Ku80, and a large catalytic subunit, DNA-PKcs. To examine the role of DNA-PKcs in lymphocyte development, radiation sensitivity, and tumorigenesis, we disrupted the mouse DNA-PKcs by homologous recombination. DNA-PKcs-null mice exhibit neither growth retardation nor a high frequency of T cell lymphoma development, but show severe immunodeficiency and radiation hypersensitivity. In contrast to the Ku70-/- and Ku80-/- phenotype, DNA-PKcs-null mice are blocked for V(D)J coding but not for signal-end joint formation. Furthermore, inactivation of DNA-PKcs leads to hyperplasia and dysplasia of the intestinal mucosa and production of aberrant crypt foci, suggesting a novel role of DNA-PKcs in tumor suppression. |
Keywords: |
dna-binding proteins; exons; nonhuman; flow cytometry; animal cell; mouse; phenotype; animals; mice; mice, knockout; gene; cell survival; complex formation; reverse transcription polymerase chain reaction; cell maturation; embryo; genotype; immunoglobulin; mice, scid; carcinogenesis; animalia; transcription factors; cell transformation, neoplastic; nuclear proteins; t lymphocyte receptor; gene rearrangement; reverse transcriptase polymerase chain reaction; protein-serine-threonine kinases; hyperplasia; immunoblotting; simian virus 40; cell line, transformed; dimerization; tumor; vdj recombinases; intestinal neoplasms; catalytic domain; lymphocyte; immunologic deficiency syndromes; dna helicases; macromolecular substances; enzyme active site; precancerous conditions; radiation tolerance; southern blotting; dna dependent protein kinase; gamma rays; dna nucleotidyltransferases; intestinal mucosa; dna-activated protein kinase; antigens, nuclear; cesium radioisotopes; priority journal; article
|